My site

SAN FRANCISCO-Thursday 6 August 2020 [ AETOS Wire ]

Reports Highest Quarterly Revenue and Bookings in Zynga History

Generates Best Quarterly Operating Cash Flow in More Than Eight Years

Raises Full Year 2020 Revenue and Bookings Guidance

(BUSINESS WIRE)-- Zynga Inc. (Nasdaq: ZNGA) today released financial results for its second quarter ended June 30, 2020 by posting management’s Q2 2020 Quarterly Earnings Letter to its Investor Relations website. Please see the attached Quarterly Earnings Letter or visit http://investor.zynga.com/financial-information/quarterly-results to access the letter.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200805005297/en/

“We delivered tremendous results in Q2, achieving our highest quarterly revenue and bookings and generating Zynga’s best quarterly operating cash flow in more than eight years. We also execute ... Read more »

SAN FRANCISCO -Thursday 6 August 2020 [ AETOS Wire ]

    Entry into One of the Largest and Fastest Growing Mobile Game Categories
    Exciting Portfolio of Popular Hyper-Casual Games with more than 5 Million Mobile DAUs and 65 Million Mobile MAUs
    Expands and Diversifies Zynga’s Advertising Business
    Adds a Highly Talented Team and Extensive Network of External Developers
    Acquisition Expected to Close on October 1, 2020

(BUSINESS WIRE)-- Zynga Inc. (Nasdaq: ZNGA), a global leader in interactive entertainment, today announced it has entered into an agreement to acquire Istanbul-based Rollic, a mobile games developer and publisher with an exciting portfolio of popular hyper-casual games that have been downloaded more than 250 million times. With this acquisition, Zynga enters the hyper-casual market – one of the largest and fastest growing gaming categories on mobile – ... Read more »

EyeArt is the First FDA Cleared AI Technology for Autonomous Detection of Both More than mild and Vision-Threatening Diabetic Retinopathy

LOS ANGELES-Thursday 6 August 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Eyenuk, Inc., a global artificial intelligence (AI) medical technology and services company and the leader in real-world applications for AI Eye Screening, announced today that it has received 510(k) clearance (K200667) by the U.S. Food & Drug Administration (FDA) to market its EyeArt® autonomous AI System for diabetic retinopathy, a leading cause of blindness among American adults.

EyeArt is indicated for use by healthcare providers to automatically detect more than mild diabetic retinopathy (mtmDR) and vision-threatening diabetic retinopathy (vtDR) in eyes of adults diagnosed with diabetes who have not been previously diagnosed with more than mild diabetic retinopathy. EyeArt is the first FDA cleared autonomous AI technology that can detect both m ... Read more »

ST GALLEN, Switzerland-Thursday 6 August 2020 [ AETOS Wire ]

    Net sales and EBITDA continued to grow in H1 2020 despite challenging market conditions due to COVID-19
    Ferinject®/ Injectafer® demand impacted by global COVID-19 restrictions
    Sustained growth in nephrology supported by dialysis business
    Veltassa® net sales impacted by reduced promotion to nephrologists due to COVID-19
    Etienne Jornod stepped down as Executive Chairman; Stefan Schulze appointed CEO of Vifor Pharma Group and Jacques Theurillat elected non-executive Chairman in May 2020
    Financial guidance 2020 updated to reflect COVID-19 impact

(BUSINESS WIRE) -- Regulatory News:

Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic. The financial guidance has been updated to reflect COVID-19 ... Read more »

ST GALLEN, Switzerland-Thursday 6 August 2020 [ AETOS Wire ]

    Net sales and EBITDA continued to grow in H1 2020 despite challenging market conditions due to COVID-19
    Ferinject®/ Injectafer® demand impacted by global COVID-19 restrictions
    Sustained growth in nephrology supported by dialysis business
    Veltassa® net sales impacted by reduced promotion to nephrologists due to COVID-19
    Etienne Jornod stepped down as Executive Chairman; Stefan Schulze appointed CEO of Vifor Pharma Group and Jacques Theurillat elected non-executive Chairman in May 2020
    Financial guidance 2020 updated to reflect COVID-19 impact

(BUSINESS WIRE) -- Regulatory News:

Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic. The financial guidance has been updated to reflect COVID-19 ... Read more »